Demineralized Bone Matrix Market Report 2026

Demineralized Bone Matrix Market Overview

• Demineralized Bone Matrix market size has reached to $1.12 billion in 2025 • Expected to grow to $1.52 billion in 2030 at a compound annual growth rate (CAGR) of 6.3% • Growth Driver: Increasing Prevalence Of Orthopedic Disorders Fueling The Growth Of The Market Due To Aging Population And Chronic Conditions • Market Trend: Innovative DBM Enhancements Elevating Surgical Precision And Fusion Outcomes • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Demineralized Bone Matrix Market?

Demineralized bone matrix (DBM) is an allograft bone product made by removing the mineral content from human bone, leaving behind the organic collagen matrix and growth factors. This process preserves proteins such as bone morphogenetic proteins (BMPs), which help promote new bone formation. DBM is commonly used in orthopedic and dental procedures to support bone healing and regeneration. The main product types of demineralized bone matrix are gel, putty, sponge, fiber, paste, and other products. Gel demineralized bone matrix (DBM) refers to a formulation of demineralized bone matrix that is suspended in a biocompatible carrier, such as glycerol, hyaluronic acid, or saline-based solutions, creating a moldable and injectable gel-like consistency. The tissue sources for demineralized bone matrix include allograft and xenograft materials and are applied across a range of medical procedures, including dental, craniomaxillofacial, spinal fusion, long bone surgeries, joint reconstruction, and others. The primary end users include hospitals, ambulatory surgical centers, specialty clinics, and others.

What Is The Demineralized Bone Matrix Market Growth Forecast?

The demineralized bone matrix market size is expected to see strong growth in the next few years. It will grow to $1.52 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to innovation in bioactive gels and collagen matrices, rising spinal fusion and joint reconstruction surgeries, expansion of specialty clinics and ambulatory surgical centers, increasing regulatory approvals and quality certifications, integration of minimally invasive surgical techniques. Major trends in the forecast period include rising adoption of demineralized bone matrix in orthopedic surgeries, increased use in dental and craniomaxillofacial procedures, growth in spinal fusion and long bone reconstruction applications, development of injectable and thermosensitive gel products, focus on collagen-based and bioactive bone regeneration materials.

Global Demineralized Bone Matrix Market Segmentation

1) By Product Type: Gel, Putty, Sponge, Fiber, Paste, Other Product Types 2) By Tissue Source: Allograft, Synthetic Bone Graft Substitutes 3) By Application: Dental, Craniomaxillofacial, Spinal Fusion, Long Bone Procedures, Joint Reconstruction, Other Applications 4) By End-Use: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Uses Subsegments: 1) By Gel: Injectable Gel, Bioactive Gel, Thermosensitive Gel 2) By Putty: Moldable Putty, Radiopaque Putty, Self-Setting Putty 3) By Sponge: Resorbable Sponge, Collagen-Based Sponge, Porous Sponge 4) By Fiber: Mineralized Fiber, Non-Mineralized Fiber, Collagen Fiber Matrix 5) By Paste: Flowable Paste, Adhesive Paste, Viscous Paste 6) By Other Product Types: Sheet Matrix, Strip Matrix, Granules

What Is The Driver Of The Demineralized Bone Matrix Market?

The increasing prevalence of orthopedic disorders is expected to propel the growth of the demineralized bone matrix (DBM) market going forward. Orthopedic disorders refer to conditions that affect the musculoskeletal system, including bones, joints, muscles, ligaments, tendons, and nerves. The demand for orthopedic treatments is increasing due to the aging global population, as older individuals are more prone to musculoskeletal disorders such as osteoarthritis, osteoporosis, and fractures. Demineralized bone matrix aids in orthopedic disorders by promoting bone regeneration and healing, making it an essential tool for spinal fusion, joint reconstruction, and fracture repair. It enhances recovery by providing an osteoinductive scaffold that supports natural bone growth and improves surgical outcomes. For instance, in August 2023, according to a survey study by the Institute for Health Metrics and Evaluation, a US-based public health research institute, 15% of individuals aged 30 and older had osteoarthritis in 2023, and the number of affected individuals is projected to reach around 1 billion by 2050. Therefore, the increasing prevalence of orthopedic disorders is driving the growth of the demineralized bone matrix industry.

Key Players In The Global Demineralized Bone Matrix Market

Major companies operating in the demineralized bone matrix market are Johnson and Johnson, Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings Inc, Arthrex Inc, Straumann AG, Globus Medical Inc, Integra LifeSciences Corporation, MTF Biologics, Exactech Inc, RTI Surgical, AlloSource, Cerapedics Inc, Keystone Dental Inc, Xtant Medical Holdings Inc, Hans Biomed Co Ltd, Bone Biologics Corp, SeaSpine Holdings Corporation, Orthofix Medical Inc, LifeNet Health

Global Demineralized Bone Matrix Market Trends and Insights

Major companies operating in the demineralized bone matrix market are focusing on developing innovative advancements, such as flowable demineralized fibers, to enhance graft handling, osteoinductive potential, and surgical efficiency. Flowable demineralized fibers are a moldable demineralized bone matrix composed of cortical bone fibers in a carrier, designed for easy placement and natural bone regeneration. For instance, in January 2025, LifeNet Health, Inc., a U.S.-based non-profit organization, unveiled PliaFX Flo, which aims to enhance bone graft handling, placement precision, and overall fusion outcomes. PliaF Flo introduces a flowable, carrier-free demineralized fiber technology that improves graft moldability and placement during bone fusion procedures. It delivers a dense fiber network designed to maximize natural osteoinductive potential and optimize handling in complex anatomical sites.

What Are Latest Mergers And Acquisitions In The Demineralized Bone Matrix Market?

In September 2023, Globus Medical Inc., a US-based medical device company, merged with NuVasive Inc. for an undisclosed amount. With this merger, Globus Medical aims to expand its leadership in the global spine and orthopedics market by integrating NuVasive’s expertise in minimally invasive surgical techniques and advanced intraoperative technologies. NuVasive Inc. is a U.S.-based medical device company engaged in the manufacturing of demineralized bone matrix (DBM) products under its Propel DBM line.

Regional Outlook

North America was the largest region in the demineralized bone matrix market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Demineralized Bone Matrix Market?

The demineralized bone matrix market consists of sales of puros demineralized bone matrix, bio-demineralized bone matrix (DBM), evograft, demineralized bone matrix chips, and demineralized bone matrix sheets. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.